News

Further research has provided more evidence to suggest that individuals who take aspirin have a lower risk of dying from cancer. Researchers looked at data from two very large studies that followed groups of nurses and other healthcare professionals (more than 130,000 people in total) over a period of up to 32 years...

The Add-Aspirin Trial is pleased to formally notify sites of the Substantial Amendment for Protocol version 5.0 and updated participant materials...

Lead researcher Professor Ruth Langley was delighted to accept a donation of £45,000 on behalf of CRUK from the Putney, Barnes, Sheen and Kew Group of Friends of Cancer Research UK. This donation was a result of the South West London Christmas Fair fundraising event organised by the group in November 2016.

We are thrilled to have more than 2000 patients registered on Add-Aspirin in the New Year, which reflects the hard work and dedication of site staff over the festive season. 1000 participants have now been registered in the breast cohort, and more than 1400 participants have been randomised overall...

Please note the Randomisation phoneline will be closed from 5pm on 23rd December until 2nd Jan and will reopen at 9am on 3rd January 2017...